The company secured the order from Hyosung T&D India and the delivery is scheduled for the next financial year
Stocks to Watch, Feb 19, 2025: From Airtel to L&T, here is a list of few stocks that will remain in focus today
The private sector bank estimates the loss amount at Rs 18.57 crore and the impact on the bank is estimated at Rs 18.87 crore
The company recorded a net profit for Q3 at Rs 34.78 crore as compared to Rs 111.3 crore a year ago, down 69 per cent
As per National Stock Exchange (NSE) bulk deal data, Morgan Stanley IFSC Fund offloaded 7,58,091 shares at Rs 588.74 per share via bulk deal
Stocks to Watch, Feb 18, 2025: Airtel, NTPC, Power Grid and other stocks will be on investors' radar today
RVNL posted a 13 per cent decline in consolidated net profit to Rs 311.58 crore as compared to a profit of Rs 358.57 crore a year ago
During Q3 FY25, the company won a tunnel project worth Rs 1,136 crore in the Kozhikode and Wayanad districts of Kerala on an engineering, procurement, and construction (EPC) basis
Bank's gross non-performing asset (GNPA) stood at Rs 1,176.76 crore as compared to Rs 718.73 crore in Q2
The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago
Stocks to Watch, Feb 17, 2025: Investors will eye stocks of companies that will and have released their Q3 results; ABFRL, Glenmark, SAIL and other will be in focus
In Q3, Concord Biotech reported a 2 per cent decline in consolidated net profit to Rs 75.9 crore as compared to Rs 77.6 crore a year ago
The company's total revenue from operations slipped 15 per cent to Rs 848.1 crore, compared to Rs 9,960.1 crore year-on-year (Y-o-Y)
In its investor presentation, the company management said that they are building further category growth while driving the share of premium in our portfolio remains a key focus
Anupam Rasayan reported a 53 per cent increase in consolidated net profit during the third quarter to Rs 28.19 crore, as compared to Rs 18.4 crore in Q3FY24.
Manappuram's total revenue from operations rose 13.6 per cent to Rs 2516.27 crore, compared to Rs 2214.2 crore year-on-year (Y-o-Y). The company's net interest income also rose 5 per cent
Suven Pharma reported a 78 per cent rise in consolidated net profit during the third quarter to Rs 83.29 crore, as compared to Rs 46.75 crore in Q3FY24
On Wednesday, after market hours, P N Gadgil reported a 49 per cent rise in consolidated profit to Rs 86.03 as compared to Rs 57.6 crore a year ago
On Wednesday, after market hours, Godrej Industries reported a 77 per cent rise in consolidated profit to Rs 188 as compared to Rs 106 crore a year ago
The company reported its Q3 numbers after market hours on Wednesday which showed a 16.38 per cent fall in consolidated profit to Rs 212.78 as compared to Rs 254.45 crore a year ago